Skip to main content
. 2023 Feb 15;13(3):729–749. doi: 10.1007/s13555-023-00892-5

Table 3.

Conditions where JAK inhibitor use is not appropriate

JAK inhibitor use has higher risks in the following conditions:
 Active cancer (or history of several cancers)
 Active or recurrent shingles despite vaccination
 Severe recurrent infections and/or frequent hospitalizations for serious infections
 Previous DVT and/or high risk for DVT without receiving anticoagulation
 Pregnancy, breast-feeding, and/or patients considering pregnancy
 Patients receiving other immunosuppressive therapies, such as transplant patients
 Severe organ failure such as decompensated cirrhosis and end-stage renal disease requiring dialysis due to limited data in these populations